• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估土耳其足月和近足月婴儿重度高胆红素血症发展的危险因素。

Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey.

机构信息

Ali Bulbul, MD, Department of Pediatrics, Division of Neonatology, Sisli Hamidiye Etfal Children Hospital, Istanbul, Turkey.

Nihal Cayonu, MD, Department of Pediatrics, Division of Neonatology, Sisli Hamidiye Etfal Children Hospital, Istanbul, Turkey.

出版信息

Pak J Med Sci. 2014 Sep;30(5):1113-8. doi: 10.12669/pjms.305.5080.

DOI:10.12669/pjms.305.5080
PMID:25225537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4163243/
Abstract

OBJECTIVE

To determine clinical features, etiology and risk factors in term and near term newborns with severe hyperbilirubinemia.

METHODS

During ten years period (2000 - 2009), infants of ≥ 35 gestational weeks who received phototherapy were evaluated retrospectively. The study population was divided into two groups and clinical features, etiology and risk factors were compared. Group 1 defined by those who had bilirubin level ≥25 mg/dl (severe hyperbilirubinemia) and group 2 defined by bilirubin level <25 mg/dl.

RESULTS

During the study period 1335 babies were evaluated. Severe hyperbilirubinemia was found in 137 (10.3%) patients. Total serum bilirubin level was 29.7±4.7 mg/dl in group 1 and 18.9±3.5 mg/dl in group 2. Pathological weight loss, vaginal delivery and supplementary feeding were identified as significant risk factors for development of severe hyperbilirubinemia (p <0.001, p <0.001 and p = 0.04, respectively). The time at recognition of jaundice by family and postnatal age at admission were significantly higher in group 1. The ratios of previous sibling received phototherapy and being the second child or after were found higher in group 1.

CONCLUSION

Pathological weight loss, vaginal delivery and supplementary feeding were determined as risk factors for development of severe hyperbilirubinemia. The newborns with severe hyperbilirubinemia had late recognition of jaundice and admission to hospital by their families.

摘要

目的

确定足月和近足月新生儿重度高胆红素血症的临床特征、病因和危险因素。

方法

在十年期间(2000 年至 2009 年),回顾性评估了接受光疗的≥35 孕周的婴儿。研究人群分为两组,比较了临床特征、病因和危险因素。第 1 组定义为胆红素水平≥25mg/dl(重度高胆红素血症),第 2 组定义为胆红素水平<25mg/dl。

结果

在研究期间,评估了 1335 名婴儿。137 名(10.3%)患儿出现重度高胆红素血症。第 1 组总血清胆红素水平为 29.7±4.7mg/dl,第 2 组为 18.9±3.5mg/dl。病理性体重下降、阴道分娩和补充喂养被确定为重度高胆红素血症发生的显著危险因素(p<0.001、p<0.001 和 p=0.04)。第 1 组家庭发现黄疸的时间和入院时的产后年龄明显较高。第 1 组中,有前一个同胞接受光疗和第二个孩子或以后的比例较高。

结论

病理性体重下降、阴道分娩和补充喂养被确定为重度高胆红素血症发生的危险因素。重度高胆红素血症新生儿的黄疸发现和家庭入院时间较晚。

相似文献

1
Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey.评估土耳其足月和近足月婴儿重度高胆红素血症发展的危险因素。
Pak J Med Sci. 2014 Sep;30(5):1113-8. doi: 10.12669/pjms.305.5080.
2
An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.对具有ABO血型不合的选择性高危新生儿群体,早期(第六小时)血清胆红素测量有助于预测显著高胆红素血症和严重ABO溶血病的发生。
Pediatrics. 2002 Apr;109(4):e53. doi: 10.1542/peds.109.4.e53.
3
Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns.近足月儿和足月儿高胆红素血症的发病率、病程及预测
Pediatrics. 2004 Apr;113(4):775-80. doi: 10.1542/peds.113.4.775.
4
Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.锡-中卟啉对耶和华见证会新生儿严重高胆红素血症的阻断作用,作为换血疗法的替代方案
Pediatrics. 2001 Dec;108(6):1374-7. doi: 10.1542/peds.108.6.1374.
5
Is breastfeeding really favoring early neonatal jaundice?母乳喂养真的会导致早期新生儿黄疸吗?
Pediatrics. 2001 Mar;107(3):E41. doi: 10.1542/peds.107.3.e41.
6
Clinical rounds in the well-baby nursery: treating jaundiced newborns.健康婴儿护理室的临床查房:治疗黄疸新生儿
Pediatr Ann. 1995 Oct;24(10):547-52. doi: 10.3928/0090-4481-19951001-10.
7
The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns.首日胆红素测量对预测健康足月儿发生显著高胆红素血症的价值。
Pediatrics. 2000 Aug;106(2):E16. doi: 10.1542/peds.106.2.e16.
8
[Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].脐血胆红素水平对新生儿后续黄疸的预测价值
Zhonghua Er Ke Za Zhi. 2007 Nov;45(11):848-52.
9
Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.使用胆红素生成抑制剂锡-中卟啉控制足月儿的严重高胆红素血症。
Pediatrics. 1999 Jan;103(1):1-5. doi: 10.1542/peds.103.1.1.
10
A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.单剂量的锡-中卟啉可预防葡萄糖-6-磷酸脱氢酶缺乏的新生儿发生严重高胆红素血症。
Pediatrics. 2001 Jul;108(1):25-30. doi: 10.1542/peds.108.1.25.

引用本文的文献

1
Maternal blood parameters and risk of neonatal pathological jaundice: a retrospective study.母血参数与新生儿病理性黄疸风险的关系:一项回顾性研究。
Sci Rep. 2023 Feb 14;13(1):2627. doi: 10.1038/s41598-023-28254-3.
2
Relationship between asymptomatic rotavirus infection and jaundice in neonates: a retrospective study.无症状轮状病毒感染与新生儿黄疸的关系:一项回顾性研究。
BMC Pediatr. 2018 Nov 30;18(1):376. doi: 10.1186/s12887-018-1352-z.

本文引用的文献

1
Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in the South of iran (fars province).伊朗南部(法尔斯省)新生儿重度高胆红素血症的发病率、危险因素及病因
Iran Red Crescent Med J. 2013 Mar;15(3):260-3. doi: 10.5812/ircmj.3337. Epub 2013 Mar 5.
2
An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation.胎龄小于 35 周的早产儿高胆红素血症的处理方法。
J Perinatol. 2012 Sep;32(9):660-4. doi: 10.1038/jp.2012.71. Epub 2012 Jun 7.
3
Incidence and causes of severe neonatal hyperbilirubinemia in Canada.加拿大新生儿重症高胆红素血症的发病率及病因
CMAJ. 2006 Sep 12;175(6):587-90. doi: 10.1503/cmaj.060328.
4
An evidence-based review of important issues concerning neonatal hyperbilirubinemia.关于新生儿高胆红素血症重要问题的循证综述。
Pediatrics. 2004 Jul;114(1):e130-53. doi: 10.1542/peds.114.1.e130.
5
Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.孕35周及以上新生儿高胆红素血症的管理
Pediatrics. 2004 Jul;114(1):297-316. doi: 10.1542/peds.114.1.297.
6
Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus.在美国,为预防核黄疸,临床迫切需要准确且精确的胆红素测量。
Clin Chem. 2004 Mar;50(3):477-80. doi: 10.1373/clinchem.2003.024489. Epub 2004 Jan 15.
7
[Breast feeding during the first few days after birth: sometimes insufficient].
Ned Tijdschr Geneeskd. 2003 Dec 6;147(49):2405-7.
8
Management of hyperbilirubinemia in newborns: measuring performance by using a benchmarking model.新生儿高胆红素血症的管理:使用基准模型衡量绩效。
Pediatrics. 2003 Dec;112(6 Pt 1):1264-73. doi: 10.1542/peds.112.6.1264.
9
Difference in plasma bilirubin concentration between monozygotic and dizygotic newborn twins.单卵和双卵新生儿双胞胎之间血浆胆红素浓度的差异。
Acta Paediatr. 2003 May;92(5):569-73.
10
Guidelines for treatment of neonatal jaundice. Is there a place for evidence-based medicine?新生儿黄疸治疗指南。循证医学是否有用?
Acta Paediatr. 2001 Mar;90(3):239-41.